Charity’s life took an unexpected turn when she was taken from her village to Abuja, Nigeria’s bustling capital, by a relative who promised her a better life. However, upon arrival, those promises crumbled into a harsh reality. Charity was forced to work as a waiter and sex worker in the restaurant and guest house owned by her relative. Her life was fraught with exploitation and abuse.
MHRP and partners across four continents recently launched a new collaborative HIV cure research initiative called DELIVER, or Developing Leadership and Innovation in Viral Eradication Research.
MHRP is partnering with the Makerere University Walter Reed Project (MUWRP) in Uganda to conduct a novel HIV vaccine study called “RapidVax,” which recently started in March 2024. This study (RV591) combines experimental HIV vaccines with a novel dose escalation strategy with the goal of improving the body’s immune response.
MHRP, through an international collaboration, just launched a new study (RV584) in Tanzania to test novel long-acting bispecific antibody alone and in combination with another potent monoclonal antibody (mAb) to determine and compare safety and antiviral effects, or how effective these drugs are at reducing the amount of HIV in people living with HIV, both alone and in combination.